COYA Long Call Strategy

COYA (Coya Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders.

COYA (Coya Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $100.1M, a beta of 0.62 versus the broader market, a 52-week range of 3.71-7.75, average daily share volume of 167K, a public-listing history dating back to 2022, approximately 8 full-time employees. These structural characteristics shape how COYA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.62 indicates COYA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on COYA?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current COYA snapshot

As of June 30, 2026, spot at $5.95, ATM IV 242.30%, IV rank 49.76%, expected move 69.47%. The long call on COYA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long call structure on COYA specifically: COYA IV at 242.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 69.47% (roughly $4.13 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COYA expiries trade a higher absolute premium for lower per-day decay. Position sizing on COYA should anchor to the underlying notional of $5.95 per share and to the trader's directional view on COYA stock.

COYA long call setup

The COYA long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COYA near $5.95, the first option leg uses a $5.95 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COYA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COYA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$5.95N/A

COYA long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

COYA long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on COYA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on COYA

Long calls on COYA express a bullish thesis with defined risk; traders use them ahead of COYA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

COYA thesis for this long call

The market-implied 1-standard-deviation range for COYA extends from approximately $1.82 on the downside to $10.08 on the upside. A COYA long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current COYA IV rank near 49.76% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on COYA should anchor more to the directional view and the expected-move geometry. As a Healthcare name, COYA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COYA-specific events.

COYA long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COYA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COYA alongside the broader basket even when COYA-specific fundamentals are unchanged. Long-premium structures like a long call on COYA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current COYA chain quotes before placing a trade.

Frequently asked questions

What is a long call on COYA?
A long call on COYA is the long call strategy applied to COYA (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With COYA stock trading near $5.95, the strikes shown on this page are snapped to the nearest listed COYA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are COYA long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the COYA long call priced from the end-of-day chain at a 30-day expiry (ATM IV 242.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a COYA long call?
The breakeven for the COYA long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current COYA market-implied 1-standard-deviation expected move is approximately 69.47%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on COYA?
Long calls on COYA express a bullish thesis with defined risk; traders use them ahead of COYA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current COYA implied volatility affect this long call?
COYA ATM IV is at 242.30% with IV rank near 49.76%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related COYA analysis